Atlas Trials

Evaluation of the Safety and Efficacy of TXA127 (Angiotensin 1-7) to Enhance Engraftment in Pediatric Patients Undergoing Single or Double Umbilical Cord Blood Transplantation

Clinical trial NCT01554254 · WITHDRAWN

Trial details

NCT number
NCT01554254
Sponsor
Tarix Pharmaceuticals
Status
WITHDRAWN
Phase
Phase 2
Study type
INTERVENTIONAL
Cord Blood TransplantHematologic MalignancyInherited Metabolic Disease
Start date
2012-03-01
Primary completion
2013-12-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.